Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Adult ID

Epi & Infection Control

Global ID

Investigative ID

HIV-STD-TB

Pediatric ID

Trainee

Transplant
Symposium

257 - Vaccines for Herpes Viruses

Saturday, October 14, 2023
1:45 PM – 3:00 PM US ET
Location: 107 ABC

Live Streamed On Demand
All relevant financial disclosures have been mitigated.
Disclosure(s):
Christine Johnston, MD, MPH: Assembly Biosciences: Advisor/Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • describe development of novel HSV vaccines that utilize mRNA technology;
  • explain the status of vaccine development for CMV infection;
  • explain why a vaccine for EBV is needed and describe the current status of EBV vaccine development.

Presentations:

  • 1:45 PM – 2:10 PM US ET
    EBV Vaccines: The Why and the How

    Speaker: Jeffrey I. Cohen, MD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  • 2:10 PM – 2:35 PM US ET
    HSV: Development of mRNA Vaccines

    Speaker: Christine Johnston, MD, MPH (she/her/hers) – University of Washington

  • 2:35 PM – 3:00 PM US ET
    CMV Vaccines: Where Are We Now?

    Speaker: Sallie Permar, MD, PhD (she/her/hers) – New York Presbyterian/Weill Cornell Medicine